Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Do, Young Rok  [Clear All Filters]
2018
Lee G-W, Park SWoo, Go S-I, Kim H-G, Kim MKyoung, Min C-K, Kwak J-Y, Bae S-B, Yoon S-S, Lee J-J, et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.
2022
Kim KHa, Lee JHoon, Lee M, Kim H-G, Do YRok, Park Y, Oh SYong, Shin H-J, Kim WSeog, Park S-K, et al. Busulfan, Melphalan, and Etoposide (Bume) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High Risk Non-Hodgkin's Lymphoma: A Mul. Cancer Res Treat. 2022.
Yi JHo, Jeong SHyun, Kim SJin, Yoon DHyun, Kang HJin, Koh Y, Kim JSeok, Lee W-S, Yang D-H, Do YRok, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer Res Treat. 2022.
2023
Kim M, Lee J-J, Min C-K, Lee JYun, Jo J-C, Yoon S-S, Lim S-N, Do YRok, Kim K, Lee JHoon, et al. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). Ann Hematol. 2023.
Kim SJin, Jo J-C, Yoon DHyun, Yang D-H, Yoon SEun, Lee G-W, Kong JHyun, Park Y, Kang K-W, Lee H-S, et al. Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation. Front Oncol. 2023;13:1230629.
Cho H, Yoon DHyun, Shin D-Y, Koh Y, Yoon S-S, Kim SJin, Do YRok, Lee G-W, Kwak J-Y, Park Y, et al. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404). Cancer Res Treat. 2023.
Kim DJung, Jeong S, Kong SGim, Lee S, Lim S-N, Oh SYong, Do YRok, Lee WSik, Lee MHong, Bae SHwa, et al. Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea. Sci Rep. 2023;13(1):2551.
Jung EHee, Byun JMin, Shin D-Y, Do YRok, Jo J-C, Lee SMin, Yoon S-S. Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer Med. 2023.
2024
Kim YRi, Shin HJin, Yhim H-Y, Yang D-H, Park Y, Lee JHyun, Lee W-S, Do YRok, Mun Y-C, Kim DSik, et al. Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in diffuse large B-cell lymphoma: a multicenter retrospective study. Front Oncol. 2024;14:1363385.